Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multicenter, Randomized, Double-Blind, Three-Arm Study to Evaluate the Efficacy and Safety of Tramadol Infusion (AVE-901) Versus Placebo and Morphine in the Management of Postoperative Pain Following Abdominoplasty

NCT03774836 is registered in ClinicalTrials.gov with Avenue Therapeutics, Inc. as lead sponsor.

NCT NCT03774836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03774836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multicenter, Randomized, Double-Blind, Three-Arm Study to Evaluate the Efficacy and Safety of Tramadol Infusion (AVE-901) Versus Placebo and Morphine in the Management of Postoperative Pain Following Abdominoplasty
Lead sponsor
Avenue Therapeutics, Inc.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 14, 2018
Completion date
June 30, 2019
Enrollment
360 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pain management